Mobile

A NON-INVASIVE EVALUATION OF BONE MICROARCHITECTURE MODIFICATION IN OSTEOPENIC POSTMENOPAUSAL WOMEN BY 3D-PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY : A 24-MONTH, MONOCENTER, DOUBLE-BLIND, RANDOMIZED...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-005598-30

A NON-INVASIVE EVALUATION OF BONE MICROARCHITECTURE MODIFICATION IN OSTEOPENIC POSTMENOPAUSAL WOMEN BY 3D-PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY : A 24-MONTH, MONOCENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP STUDY COMPARING WEEKLY ORAL RISEDRONATE 35 MG AND PLACEBO

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to compare risedronate 35 mg and placebo with respect to percent change at 12-month for distal radius trabecular bone volume (BV/TV) in osteopenic postmenopausal women as measured by 3D-pQCT.

Critère d'inclusion

  • Osteopenic postmenopausal women

Liens